Waddill William D. 4
4 · ARROWHEAD PHARMACEUTICALS, INC. · Filed Dec 18, 2025
Insider Transaction Report
Form 4
Waddill William D.
Director
Transactions
- Award
Common Stock
2025-12-16+7,819→ 64,930 total
Footnotes (1)
- [F1]Represents shares underlying restricted stock units, which shares will vest in one installment on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer on such date.